![Shao Lee Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shao Lee Lin
Algemeen Directeur bij
CUE BIOPHARMA, INC.
Vermogen: 18 M $ op 31-07-2026
Profiel
Shao Lee Lin was the founder of ACELYRIN, Inc., founded in 2020, serving as Chief Executive Officer & Director from 2020 to 2024.
Current jobs include President, Chief Executive Officer & Director at Cue Biopharma, Inc. since 2026, and Director at Surrozen Operating, Inc. since 2021.
Former jobs include Director at Principia Biopharma, Inc. from 2019 to 2020; Independent Director at Surrozen, Inc. from 2021 to 2026; Independent Director at Third Harmonic Bio, Inc. from 2020 to 2023; VP-Inflammation & Respiratory Development at Gilead Sciences, Inc. from 2012 to 2015; VP-Therapeutic Areas & Development Excellence at AbbVie, Inc. from 2015 to 2017; Chief Scientific Officer, EVP, Head-R&D at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020; and Trustee at Lake Forest College from 2018 to 2020.
Education includes undergraduate studies at William Marsh Rice University and a doctorate from The Johns Hopkins University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 15,6% | 09-07-2026 | 655.074 ( 15,6% ) | 18 M $ | 31-07-2026 |
SURROZEN INC 0,02% | 14-05-2025 | 2.341 ( 0,02% ) | 51 994 $ | 31-07-2026 |
Actieve functies van Shao Lee Lin
| Bedrijven | Functie | Begin |
|---|---|---|
| CUE BIOPHARMA, INC. | Algemeen Directeur | 30-04-2026 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Directeur/Bestuurslid | 02-02-2021 |
Eerdere bekende functies van Shao Lee Lin
| Bedrijven | Functie | Einde |
|---|---|---|
| SURROZEN, INC. | Directeur/Bestuurslid | 26-01-2026 |
| ACELYRIN, INC. | Oprichter | 08-05-2024 |
| THIRD HARMONIC BIO, INC. | Directeur/Bestuurslid | 17-01-2023 |
| PRINCIPIA BIOPHARMA INC. | Directeur/Bestuurslid | 28-09-2020 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Hoofd Techniek/Wetenschap/O&O | 23-01-2020 |
Opleiding van Shao Lee Lin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
61
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lake Forest College
 Lake Forest College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
